Twice the output, half the runtime, and half the footprint of the UG 100® with greater flexibility and improved genomic ...
Element Biosciences AVITI24 5D Multiomic and AVITI next generation sequencing systems are designed to make high-performance genomics accessible to all. With its combination of accuracy, flexibility, ...
Rare diseases (RD) are more common than you might think. For every 20 people you know, one is likely affected by a rare disease. Of the 7,000 known RD conditions, 80% have a genetic origin, yet over ...
News-Medical.Net on MSN
Element Biosciences introduces VITARI™, redefining what high-throughput sequencing makes possible
Element Biosciences Inc. today announced VITARI, the first ever high-throughput benchtop sequencing system capable of delivering a high-quality whole genome at $100. With the introduction of VITARI, ...
Element Biosciences is going toe-to-toe with gene-sequencing giant Illumina, unveiling a device that can read DNA for half the price of the industry leader’s technology. On Thursday, Element ...
Normalization by Ligation™ library preparation technology processes thousands of samples at low cost with enhanced multiplexing and novel streamlined workflow SOUTH SAN FRANCISCO, Calif.--(BUSINESS ...
The key opportunities in the Global Personalized Medicine Biomarkers Market include advancements in genomic sequencing, growing reliance on targeted therapies, rising cancer and chronic disease ...
Complete Genomics, a U.S.-based, innovator in genomic sequencing platforms and solutions, today announced it is commencing shipments of DNBSEQ-T7+ high-throughput sequencing platform at the 2026 ...
Pioneering research utilizes high-throughput single-cell sequencing to demystify the microbial universe within activated sludge, a cornerstone of wastewater treatment. This study has unearthed a ...
DNA sequencing technology has become a laboratory staple, helping scientists advance genomics research by leaps and bounds. However, analyzing vast amounts of genetic material often leads to ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results